232 related articles for article (PubMed ID: 17549790)
1. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26.
Davoodi J; Kelly J; Gendron NH; MacKenzie AE
Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790
[TBL] [Abstract][Full Text] [Related]
2. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
3. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
[TBL] [Abstract][Full Text] [Related]
4. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.
DeBaun MR; Ess J; Saunders S
Mol Genet Metab; 2001 Apr; 72(4):279-86. PubMed ID: 11286501
[TBL] [Abstract][Full Text] [Related]
5. Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations.
Yano S; Baskin B; Bagheri A; Watanabe Y; Moseley K; Nishimura A; Matsumoto N; Ray PN
Clin Genet; 2011 Nov; 80(5):466-71. PubMed ID: 20950395
[TBL] [Abstract][Full Text] [Related]
6. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
Xuan JY; Hughes-Benzie RM; MacKenzie AE
J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
[TBL] [Abstract][Full Text] [Related]
7. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner.
Gonzalez AD; Kaya M; Shi W; Song H; Testa JR; Penn LZ; Filmus J
J Cell Biol; 1998 Jun; 141(6):1407-14. PubMed ID: 9628896
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic spectrum of Simpson-Golabi-Behmel syndrome in a series of 42 cases with a mutation in GPC3 and review of the literature.
Cottereau E; Mortemousque I; Moizard MP; Bürglen L; Lacombe D; Gilbert-Dussardier B; Sigaudy S; Boute O; David A; Faivre L; Amiel J; Robertson R; Viana Ramos F; Bieth E; Odent S; Demeer B; Mathieu M; Gaillard D; Van Maldergem L; Baujat G; Maystadt I; Héron D; Verloes A; Philip N; Cormier-Daire V; Frouté MF; Pinson L; Blanchet P; Sarda P; Willems M; Jacquinet A; Ratbi I; Van Den Ende J; Lackmy-Port Lis M; Goldenberg A; Bonneau D; Rossignol S; Toutain A
Am J Med Genet C Semin Med Genet; 2013 May; 163C(2):92-105. PubMed ID: 23606591
[TBL] [Abstract][Full Text] [Related]
9. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
[TBL] [Abstract][Full Text] [Related]
10. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
Lin H; Huber R; Schlessinger D; Morin PJ
Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
[TBL] [Abstract][Full Text] [Related]
11. Mutation update for the GPC3 gene involved in Simpson-Golabi-Behmel syndrome and review of the literature.
Vuillaume ML; Moizard MP; Rossignol S; Cottereau E; Vonwill S; Alessandri JL; Busa T; Colin E; Gérard M; Giuliano F; Lambert L; Lefevre M; Kotecha U; Nampoothiri S; Netchine I; Raynaud M; Brioude F; Toutain A
Hum Mutat; 2018 Jun; 39(6):790-805. PubMed ID: 29637653
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of a novel intragenic deletion in GPC3 in three cousins with Simpson-Golabi-Behmel syndrome.
Schmidt J; Hollstein R; Kaiser FJ; Gillessen-Kaesbach G
Am J Med Genet A; 2017 May; 173(5):1400-1405. PubMed ID: 28371070
[TBL] [Abstract][Full Text] [Related]
13. A male newborn with Simpson-Golabi-Behmel syndrome, presenting with metopic synostosis, anal atresia, and total anomalous pulmonary venous return.
Demir N; Peker E; Ece I; Kaba S; Doğan M; Tuncer O
Genet Couns; 2014; 25(4):439-43. PubMed ID: 25804025
[TBL] [Abstract][Full Text] [Related]
14. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
[TBL] [Abstract][Full Text] [Related]
15. Novel nonsense mutation of GPC3 gene in a patient with Simpson-Golabi-Behmel syndrome.
Ratbi I; Elalaoui SC; Moizard MP; Raynaud M; Sefiani A
Turk J Pediatr; 2010; 52(5):525-8. PubMed ID: 21434539
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
[TBL] [Abstract][Full Text] [Related]
17. Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma.
Jakubovic BD; Jothy S
Exp Mol Pathol; 2007 Apr; 82(2):184-9. PubMed ID: 17258707
[No Abstract] [Full Text] [Related]
18. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
19. Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.
Sakurai M; Shibata K; Umezu T; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
Gynecol Oncol; 2010 Nov; 119(2):332-6. PubMed ID: 20701957
[TBL] [Abstract][Full Text] [Related]
20. A 1 Mb-sized microdeletion Xq26.2 encompassing the GPC3 gene in a fetus with Simpson-Golabi-Behmel syndrome Report, antenatal findings and review.
Weichert J; Schröer A; Amari F; Siebert R; Caliebe A; Nagel I; Gillessen-Kaesbach G; Mohrmann I; Hellenbroich Y
Eur J Med Genet; 2011; 54(3):343-7. PubMed ID: 21362501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
